Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-Coronavirus Membrane Protein (SARS-CoV M) (N-Term) Peptide

SARS-CoV M Reactivity: SARS Coronavirus (SARS-CoV) BP Sodium azide
Catalog No. ABIN1382274
  • Target See all SARS-Coronavirus Membrane Protein (SARS-CoV M) products
    SARS-Coronavirus Membrane Protein (SARS-CoV M)
    Protein Region
    N-Term
    Origin
    SARS Coronavirus (SARS-CoV)
    Application
    Blocking Peptide (BP)
    Characteristics
    14 amino acids near the amino terminus of SARS M protein.
    Virus
  • Application Notes
    SARS matrix peptide is used for blocking the activity of the SARS matrix.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    200 μg/mL
    Buffer
    PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1 % bovine serum albumin and 0.02 % sodium azide
    Preservative
    Sodium azide
    Precaution of Use
    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Expiry Date
    12 months
  • Target
    SARS-Coronavirus Membrane Protein (SARS-CoV M)
    Synonyms
    M protein Peptide, matrix protein Peptide, M Peptide
    Target Type
    Viral Protein
    Background
    Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus. The disease is the cause of the 2019–20 coronavirus outbreak. The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. The membrane (M) protein or matrix protein is the most abundant structural protein and defines the shape of the viral envelope. It is an integral membrane protein involved in the budding of the viral particles and interacts with S (Spike) protein. It involves in organization of the nucleoprotein inside, which includes many copies of the N (nucleocapsid) protein bound to the genomic RNA. The M protein holds dominant cellular immunogenicity and has been determined as a protective antigen in humoral responses, which suggests it would serve as a potential target in vaccine design.
You are here:
Support